Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare
Lifecore Biomedical, Inc. Operating Income 2010–2025
Lifecore Biomedical, Inc. annual/quarterly operating income history and growth rate from 2010 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Lifecore Biomedical, Inc. operating income for the quarter ending March 31, 2026 was -4.7 M, a 196.69% decrease year-over-year.
- Lifecore Biomedical, Inc. operating income for the twelve months ending March 31, 2026 was -18.7 M, a 17.05% decrease year-over-year.
- Lifecore Biomedical, Inc. annual operating income for 2025 was -17.2 M, a 94.99% increase from 2024.
- Lifecore Biomedical, Inc. annual operating income for 2024 was -8.8 M, a 59.42% decrease from 2023.
- Lifecore Biomedical, Inc. annual operating income for 2023 was -21.8 M, a 84.85% increase from 2022.
- Lifecore Biomedical, Inc. annual operating income for 2022 was -11.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lifecore Biomedical, Inc. Operating Income — FAQ
Lifecore Biomedical, Inc. (LFCR) operating income over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Lifecore Biomedical, Inc.'s operating income?
Lifecore Biomedical, Inc. (LFCR) reported operating income of -$17M for fiscal 2025.
Where can I see LFCR's operating income history?
The chart and table above show Lifecore Biomedical, Inc.'s operating income by year and by quarter, including the growth rate.